Monthly Prescribing Reference

Fentanyl Buccal Tablet Consistently Treats Chronic, Persistent Noncancer-Related Pain

HONOLULU, HI—Patientswith chronic, noncancer-related pain who received fentanyl buccal tablet had consistent short-term efficacy acrossclinically meaningful analgesia measures, according to results of ...
Houston Chronicle

(PRN) Cephalon's Fentanyl Effervescent Buccal Tablet Reduces Intensity of Breakthrough Pain in Cancer Patients

SAN ANTONIO, May 4 /PRNewswire-FirstCall/ -- Results of a Phase 3 clinical trial demonstrate positive results with a fentanyl effervescent buccal tablet (FEBT) in all ...
clinicaladvisor.com

Fentanyl buccal tablet better for breakthrough pain than short-acting opioids

AUSTIN, TX—In a study presented at the American Pain Society’s 30th Annual Scientific Meeting, fentanyl buccal tablet (FBT) was shown to be more effective than traditional short-acting opioids (SAO) ...
Monthly Prescribing Reference

Fentanyl Buccal Tablets Recalled Due to Omitted Safety Updates in Labeling

Credit: Teva Pharmaceuticals. Teva Pharmaceuticals is recalling certain lots of Fentanyl Buccal Tablets CII because safety updates were omitted in the product insert/medication guide. Teva ...
FierceBiotech

FDA Approves Oravig(TM) (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis

First and Only Local, Oral Prescription Formulation of Miconazole Approved for Thrush in the United States WOODCLIFF LAKE, N.J., April 16, 2010 /PRNewswire via COMTEX/ --Strativa Pharmaceuticals today ...